Beita profile
Beita Pharmatech is a professional enterprise specializing in the development of carbon-14 source materials, carbon-14 and carbon-13 precursors, isotope-labeled internal standards for disease detection via tandem mass spectrometry, and breath test diagnostic reagents. We also deliver high-quality carbon-14/tritium and carbon-13/deuterium isotope labeling services.
Headquartered in Wuxi, Beita operates branch sites in Changsha and Shanghai.
- Wuxi Beita focuses on developing carbon-14 source materials, carbon-14/tritium precursors, automated radiosynthesis equipment, and breath test diagnostic reagents, while providing carbon-14 and tritium radioisotope labeling services.
- Changsha Beita concentrates on carbon-14/carbon-13 precursors and isotope-labeled internal standards for disease detection using tandem mass spectrometry, and offers stable and radioisotope labeling services for carbon-14, carbon-13, deuterium and nitrogen-15.
Beita has established the R. H. Grubbs Institute of Isotopic Synthesis and the Zhou Yongmao Academician Workstation. These platforms bring together world-leading experts and cultivate a highly trained technical team. Supported by this talent pool, Beita continues to supply premium isotope-labeled products and custom labeling services to customers across the globe.
Our Track Record
Wuxi Beita has built a fully integrated ¹⁴C & ³H industrial chain and is a China leader in radioisotope labeling.
18+ Years of isotope labeling expertise
1,000+ ¹⁴C / ³H-labeled precursors
600+ ¹⁴C / ³H-labeled drugs & drug candidates
300+ Customers
100+ Patents & publications
Beta News
Industry News
Cooperation Unit
Nuclear Power Institute of China
China Academy of Atomic Energy
RC TRITEC
Cambridge Isotope Laboratories, Inc.
Jiangsu Yongda Pharmaceutical Co.,ltd.
Kelun Industry Group